R&D

New 3D printing research paves way for personalised medication

A new technique for 3D printing medication has enabled the printing of multiple drugs in a single tablet, paving the way for personalised pills that can deliver timed doses. Researchers...

View the Online Magazine

Latest Issue

Magazine Archive

Launches

Beckman Coulter’s DxI 9000 Immunoassay Analyzer extends menu with new CE-marked hepatitis assays at ESCMID Global

Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases...

Getinge and CellRev launch pioneering adherent cell expansion platform

CellRev, in partnership with Getinge, has launched a breakthrough adherent cell expansion platform, Livit ACE. Designed to eliminate many of the limitations and inefficiencies associated...

Data on over 2,300 lung cancer biomarkers mapped in new global database

A new database has been created to support pharmaceutical and biotech companies in the creation of new drugs to treat lung cancer, bringing the...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

ACG awarded ‘Great Place To Work’ certification for a fourth consecutive year

ACG, the world’s largest integrated supplier and service provider to the pharmaceutical industry, is delighted to announce that for the fourth consecutive year, it...

Emergent BioSolutions receives $75m contract option from BARDA to procure doses of anthrax vaccine

The Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness and Response at the United States Department of Health and...

UK Health Security Agency agrees vaccine deal

The UK Health Security Agency (UKHSA) has agreed a deal for millions of life-saving vaccines to be produced in the UK if a future...

Menarini becomes exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (fixed-dose combination of canagliflozin and metformin) in the UK

A. Menarini Farmaceutica Internazionale SRL (Menarini) has become the exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (a fixed-dose combination of canagliflozin and metformin) in the United...

Approvals

Bristol Myers Squibb’s CAR T cell therapy Breyanzi approved by U.S. Food and Drug Administration for relapsed or refractory follicular lymphoma

The U.S. Food and Drug Administration (FDA) has granted accelerated approval for Bristol Myers Squibb's Breyanzi ® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen...

Zai Lab’s AUGTYRO approved in China for patients with ROS1-positive NSCLC

The National Medical Products Administration (NMPA) in China has approved Zai Lab's New Drug Application (NDA) for AUGTYRO™ (repotrectinib) for the treatment of adult...

New cabotegravir formulations approved to help prevent HIV-1 infection

U.S. FDA approves Neurocrine Biosciences’ INGREZZA SPRINKLE capsules

X4 Pharmaceuticals gains FDA approval for WHIM syndrome drug XOLREMDI

U.S. Food & Drug Administration approves Accord BioPharma’s HERCESSI, a biosimilar to Herceptin

Manufacturiung

Finance

Research & Development
Latest

R&D

New 3D printing research paves way for personalised medication

A new technique for 3D printing medication has enabled the printing of multiple drugs in a single tablet, paving the way for personalised pills...
R&D

AC Immune and Takeda sign agreement for active immunotherapy designed to delay Alzheimer’s disease progression

Takeda and AC Immune have announced an exclusive, worldwide option and license agreement for AC Immune’s active immunotherapies targeting toxic forms of amyloid beta...
R&D

AbbVie and Gilgamesh Pharmaceuticals to develop next-generation therapies for psychiatric disorders

AbbVie and Gilgamesh Pharmaceuticals have announced a collaboration and option-to-license agreement to develop next-generation therapies for psychiatric disorders. This collaboration will leverage AbbVie's expertise...
R&D

Fulcrum Therapeutics enters into collaboration and license agreement with Sanofi for development and commercialization of losmapimod in facioscapulohumeral muscular dystrophy

Fulcrum Therapeutics, a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, has entered...
R&D

Chiesi Group forges alliance with Karolinska Institutet to tackle urgent health challenges

Chiesi Group, a research-oriented international biopharmaceutical group, has signed a memorandum of understanding with Karolinska Institutet, a medical university. The agreement solidifies a commitment between the...

Appointments

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks